HYPERANDROGENISM AND INSULIN RESISTANCE IN WOMEN
女性雄激素过多症和胰岛素抵抗
基本信息
- 批准号:3325257
- 负责人:
- 金额:$ 11.41万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1990
- 资助国家:美国
- 起止时间:1990-04-01 至 1993-01-31
- 项目状态:已结题
- 来源:
- 关键词:androgens androstenedione female glucose metabolism graafian follicles growth factor hormone regulation /control mechanism human subject hyperglycinemia insulin insulin dependent diabetes mellitus insulin receptor insulinlike factor luteinizing hormone messenger RNA ovary somatostatin steroid hormone biosynthesis testosterone
项目摘要
Ovarian hyperandrogenism is one of the most common
endocrinopathies of reproductive age women. Proposed etiologic
mechanisms for this common clinical syndrome include primary
abnormalities of the hypothalamic-pituitary unit, the ovary and
the adrenal gland. A unique opportunity to identify a specific
molecular cause of ovarian hyperandrogenism is provided by the
observation that hyperinsulinemia is commonly associated with
hyperandrogenism. The objective of this proposal is to test the
hypothesis that insulin and insulin-like growth factors (IGFs)
regulate ovarian androgen production and metabolism in women.
Preliminary evidence indicates that insulin, IGF-1 and LH
stimulate androgen production in incubations of minced human
ovarian stroma and theca. To further explore these effects the
following experiments are planned: 1) determination of detailed
dose-response curves for insulin, IGF-1 and LH stimulation of
thecal and stomal androgen production, 2) determination of the
effects of insulin, IGF-1 and LH on androgen production in theca
obtained from healthy or atretic follicles, 3) analysis of the
binding characteristics of insulin and IGFs to insulin receptors,
and IGF-1 receptors in ovarian theca and stroma, 4) analysis of
the effects of insulin and IGFs on specific enzymes of thecal
androgen biosynthesis (e.g. 17B - hydroxysteroid dehydrogenase),
5) use dot blots to probe ovarian tissue for the presence of mRNA
for the insulin and IGF-1 receptors.
Preliminary evidence indicated that the oral administration of 100
gms of glucose to hyperinsulinemic-hyperandrogenic women
produces an acute rise in serum androstenedione, testosterone and
dihydrotestosterone. To test the effects of insulin and glucose on
circulating androstenedione and testosterone, the following
experiments are planned: 1) examine the effects of 50 gm, 100
gm and 200 gm or oral glucose; and 25 gm and 50 gm of
intravenous glucose on circulating insulin and androgens, 2)
directly test the effects of hyperinsulinemia on circulating insulin
by using a euglycemic clamp; and 3) directly test the effects of
hyperglycemia on circulating androgens by using a hyperglycemic
clamp. These experiments should yield important information
concerning the role of metabolic factors in the regulation of
ovarian androgen production and metabolism.
卵巢高雄激素血症是最常见的
育龄妇女的内分泌疾病。 拟定病因
这种常见临床综合征的机制包括原发性
下丘脑-垂体单位、卵巢和
肾上腺 一个独特的机会,以确定一个特定的
卵巢高雄激素血症的分子原因由
观察到高胰岛素血症通常与
雄激素过多症 本提案的目的是测试
胰岛素和胰岛素样生长因子(IGFs)
调节女性卵巢雄激素的产生和代谢。
初步证据表明,胰岛素、IGF-1和LH
刺激切碎人孵育中雄激素产生
卵巢基质和卵泡膜。 为了进一步探索这些影响,
计划进行以下实验:1)确定详细的
胰岛素、IGF-1和LH刺激的剂量反应曲线
卵泡膜和气孔雄激素的产生,2)测定
胰岛素、IGF-1和LH对卵泡膜雄激素产生的影响
从健康或闭锁卵泡中获得,3)分析
胰岛素和IGF与胰岛素受体的结合特性,
卵巢卵泡膜和间质中IGF-1和IGF-1受体的分析,
胰岛素和胰岛素样生长因子对卵泡膜特异性酶的影响
雄激素生物合成(例如17 β-羟基类固醇脱氢酶),
5)用斑点印迹法检测卵巢组织中mRNA的存在
胰岛素和胰岛素样生长因子1受体。
初步证据表明,口服100
高胰岛素血症-高雄激素血症妇女的葡萄糖gms
产生血清雄烯二酮,睾酮和
双氢睾酮 为了测试胰岛素和葡萄糖对
循环雄烯二酮和睾酮,以下
实验计划:1)检查50克,100克
克和200克或口服葡萄糖;和25克和50克的
静脉注射葡萄糖对循环胰岛素和雄激素的影响,2)
直接检测高胰岛素血症对循环胰岛素的影响
通过使用正葡萄糖钳夹;和3)直接测试
高血糖对循环雄激素的影响
止血钳 这些实验应该能提供重要的信息
关于代谢因素在调节
卵巢雄激素的产生和代谢。
项目成果
期刊论文数量(11)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Twenty-four-hour urinary-free cortisol in premenopausal cigarette smokers and nonsmokers.
绝经前吸烟者和不吸烟者的二十四小时尿中游离皮质醇。
- DOI:10.1016/s0015-0282(16)53177-x
- 发表时间:1989
- 期刊:
- 影响因子:6.7
- 作者:Yeh,J;Barbieri,RL
- 通讯作者:Barbieri,RL
High dietary fiber and low saturated fat intake among oligomenorrheic undergraduates.
月经稀发大学生的高膳食纤维和低饱和脂肪摄入量。
- DOI:
- 发表时间:1990
- 期刊:
- 影响因子:6.7
- 作者:Snow,RC;Schneider,JL;Barbieri,RL
- 通讯作者:Barbieri,RL
Rat Leydig cell and granulosa cell 17-ketosteroid reductase activity: subcellular localization and substrate specificity.
大鼠 Leydig 细胞和颗粒细胞 17-酮类固醇还原酶活性:亚细胞定位和底物特异性。
- DOI:10.1016/0002-9378(88)90595-9
- 发表时间:1988
- 期刊:
- 影响因子:9.8
- 作者:Barbieri,RL;Rein,MS;Hornstein,MD;Ryan,KJ
- 通讯作者:Ryan,KJ
THE EFFECTS OF ETHANOL ON THE CLEARANCE OF ESTRADIOL IN POSTMENOPAUSAL WOMEN
- DOI:10.1016/s0015-0282(16)57602-x
- 发表时间:1995-06-01
- 期刊:
- 影响因子:6.7
- 作者:GINSBURG, ES;WALSH, BW;BARBIERI, RL
- 通讯作者:BARBIERI, RL
Leuprolide acetate depot decreases the number of nucleolar organizer regions in uterine leiomyomata.
醋酸亮丙瑞林长效制剂可减少子宫平滑肌瘤中核仁组织区的数量。
- DOI:10.1016/s0015-0282(16)56177-9
- 发表时间:1993
- 期刊:
- 影响因子:6.7
- 作者:Barbieri,RL;Dilena,M;Chumas,J;Rein,MS;Friedman,AJ
- 通讯作者:Friedman,AJ
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Robert L Barbieri其他文献
Nonhormonal medication treatment of VMS
VMS 的非激素药物治疗
- DOI:
- 发表时间:
2023 - 期刊:
- 影响因子:0
- 作者:
Robert L Barbieri - 通讯作者:
Robert L Barbieri
Medication treatment of opioid use disorder in primary care practice: Opportunities and limitations
初级保健实践中阿片类药物使用障碍的药物治疗:机遇和局限性
- DOI:
10.12788/obgm.0308 - 发表时间:
2023 - 期刊:
- 影响因子:0
- 作者:
Robert L Barbieri - 通讯作者:
Robert L Barbieri
The clinical utility of newly approved angiogenic markers for identifying patients at risk for adverse outcomes due to preeclampsia
新批准的血管生成标记物在识别因先兆子痫导致不良结果风险的患者方面的临床应用
- DOI:
- 发表时间:
2023 - 期刊:
- 影响因子:0
- 作者:
Robert L Barbieri - 通讯作者:
Robert L Barbieri
Breakthroughs in the prevention of RSV disease among infants
预防婴儿 RSV 疾病的突破
- DOI:
10.12788/obgm.0323 - 发表时间:
2023 - 期刊:
- 影响因子:0
- 作者:
Robert L Barbieri - 通讯作者:
Robert L Barbieri
Anti-obesity medications: Breakthroughs and limitations
抗肥胖药物:突破和局限性
- DOI:
- 发表时间:
2023 - 期刊:
- 影响因子:0
- 作者:
Robert L Barbieri - 通讯作者:
Robert L Barbieri
Robert L Barbieri的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Robert L Barbieri', 18)}}的其他基金
Development of Scholars in Ob-Gyn for the 21th Century
21世纪妇产科学者的发展
- 批准号:
6937579 - 财政年份:1999
- 资助金额:
$ 11.41万 - 项目类别:
Development of Scholars in Ob-Gyn for the 21th Century
21世纪妇产科学者的发展
- 批准号:
7059471 - 财政年份:1999
- 资助金额:
$ 11.41万 - 项目类别:
DEVELOPMENT OF SCHOLARS IN OB-GYN FOR THE 21ST CENTURY
21世纪妇产科学者的发展
- 批准号:
6689584 - 财政年份:1999
- 资助金额:
$ 11.41万 - 项目类别:
Development of Scholars in Ob-Gyn for the 21th Century
21世纪妇产科学者的发展
- 批准号:
7631424 - 财政年份:1999
- 资助金额:
$ 11.41万 - 项目类别:
DEVELOPMENT OF SCHOLARS IN OB-GYN FOR THE 21ST CENTURY
21世纪妇产科学者的发展
- 批准号:
6329782 - 财政年份:1999
- 资助金额:
$ 11.41万 - 项目类别:
Development of Scholars in Ob-Gyn for the 21th Century
21世纪妇产科学者的发展
- 批准号:
7243341 - 财政年份:1999
- 资助金额:
$ 11.41万 - 项目类别:
Development of Scholars in Ob-Gyn for the 21th Century
21世纪妇产科学者的发展
- 批准号:
7417418 - 财政年份:1999
- 资助金额:
$ 11.41万 - 项目类别:
DEVELOPMENT OF SCHOLARS IN OB-GYN FOR THE 21ST CENTURY
21世纪妇产科学者的发展
- 批准号:
6476582 - 财政年份:1999
- 资助金额:
$ 11.41万 - 项目类别:
DEVELOPMENT OF SCHOLARS IN OB-GYN FOR THE 21ST CENTURY
21世纪妇产科学者的发展
- 批准号:
6625124 - 财政年份:1999
- 资助金额:
$ 11.41万 - 项目类别:
DEVELOPMENT OF SCHOLARS IN OB-GYN FOR THE 21ST CENTURY
21世纪妇产科学者的发展
- 批准号:
6024024 - 财政年份:1999
- 资助金额:
$ 11.41万 - 项目类别:
相似海外基金
DIETARY SUPPLEMENT ANDROSTENEDIONE AND HORMONE LEVELS IN HEALTHY MEN
健康男性膳食补充剂雄烯二酮和激素水平
- 批准号:
6586382 - 财政年份:2002
- 资助金额:
$ 11.41万 - 项目类别:
DIETARY SUPPLEMENT ANDROSTENEDIONE AND HORMONE LEVELS IN HEALTHY MEN
健康男性膳食补充剂雄烯二酮和激素水平
- 批准号:
6574349 - 财政年份:2001
- 资助金额:
$ 11.41万 - 项目类别:
DIETARY SUPPLEMENT ANDROSTENEDIONE AND HORMONE LEVELS IN HEALTHY MEN
健康男性膳食补充剂雄烯二酮和激素水平
- 批准号:
6505152 - 财政年份:2000
- 资助金额:
$ 11.41万 - 项目类别:
DIETARY SUPPLEMENT ANDROSTENEDIONE AND HORMONE LEVELS IN HEALTHY MEN
健康男性膳食补充剂雄烯二酮和激素水平
- 批准号:
6308034 - 财政年份:1999
- 资助金额:
$ 11.41万 - 项目类别:
DIETARY SUPPLEMENT ANDROSTENEDIONE AND HORMONE LEVELS IN HEALTHY MEN
健康男性膳食补充剂雄烯二酮和激素水平
- 批准号:
6265475 - 财政年份:1998
- 资助金额:
$ 11.41万 - 项目类别:
DIETARY SUPPLEMENT ANDROSTENEDIONE AND HORMONE LEVELS IN HEALTHY MEN
健康男性膳食补充剂雄烯二酮和激素水平
- 批准号:
6297936 - 财政年份:1998
- 资助金额:
$ 11.41万 - 项目类别:
DIETARY SUPPLEMENT ANDROSTENEDIONE AND HORMONE LEVELS IN HEALTHY MEN
健康男性膳食补充剂雄烯二酮和激素水平
- 批准号:
6297852 - 财政年份:1998
- 资助金额:
$ 11.41万 - 项目类别:
ANDROSTENEDIONE INCREASES ESTRADIOL LEVELS BUT NOT PRETERM LABOR
雄烯二酮会增加雌二醇水平,但不会增加早产
- 批准号:
6247230 - 财政年份:1997
- 资助金额:
$ 11.41万 - 项目类别:
EFFECT OF DIETARY SUPPLEMENT ANDROSTENEDIONE ON HORMONE LEVELS IN HEALTHY MEN
膳食补充剂雄烯二酮对健康男性激素水平的影响
- 批准号:
6286470 - 财政年份:1978
- 资助金额:
$ 11.41万 - 项目类别:
DISCRIMINATION OF OVARIAN VS ADRENAL ANDROSTENEDIONE
卵巢雄烯二酮与肾上腺雄烯二酮的区别
- 批准号:
3975067 - 财政年份:
- 资助金额:
$ 11.41万 - 项目类别: